1-3 of 3
Robert Van Horn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B229: TBKI kinase inhibition blocks RANTES secretion and exhibits minimal tumor growth inhibition in oncogenic Ras-driven tumor models.

Robert Van Horn, Tinggui Yin, Xiaoyi Zhang, Chunping Yu, Youyan Zhang, Xue-Qian Gong, Sean Buchanan, Xiang S. Ye, William McMillen, David Barda, Sheng-Bin Peng
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B229.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-B229
Published: 01 November 2013
View article
Journal Articles

Tasisulam Sodium, an Antitumor Agent That Inhibits Mitotic Progression and Induces Vascular Normalization

Timothy Meier, Mark Uhlik, Sudhakar Chintharlapalli, Michele Dowless, Robert Van Horn, Julie Stewart, Wayne Blosser, James Cook, Debra Young, Xiang Ye, Glenn Evans, Kelly Credille, Darryl Ballard, Lysiane Huber, Andrew Capen, Marcio Chedid, Robert Ilaria, Jr, Michele C. Smith, Louis Stancato
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11): 2168–2178.
DOI: https://doi.org/10.1158/1535-7163.MCT-11-0323
Published: 08 November 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract A62: A novel Eg5 inhibitor that causes mitotic arrest leading to rapid cancer cell death shows broad‐spectrum antitumor activity in preclinical xenograft tumor models

Xiang S. Ye, Li Fan, Robert Van Horn, Tinggui Yin, Ryuichiro Nakai, Yoshihisa Ohta, Kelly Credille, Gregory Donoho, Shiro Akinaga, Chikara Murakata, Everett Perkins, Scott Ocheltree, Yoshinori Yamashita, Kerry Blanchard, Eric Westin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A62.
DOI: https://doi.org/10.1158/1535-7163.TARG-09-A62
Published: 10 December 2009
View article